Kelvin Yen is a prominent inventor based in Los Angeles, CA, who has made significant contributions to the field of diabetes and obesity therapeutics. With a total of 4 patents, his work focuses on novel approaches to combat these prevalent health issues.

Latest Patents

One of his latest patents involves MENTSH analogs as therapeutics for diabetes, obesity, and their associated diseases and complications. This patent describes a novel, mitochondrial encoded open reading frame that leads to the production of a new mitochondrial peptide. A specific small nucleotide polymorphism residing within the ND-Two subunit disrupts the expression of this mitochondrial peptide, correlating with an increase in obesity and diabetes, particularly in certain ethnic populations. In vitro administration of the peptide has shown to increase insulin secretion, decrease fat accumulation, and improve glucose uptake in muscle cells. Furthermore, antibodies generated against the peptide can be utilized for detecting peptide deficiency and SNP detection, supporting diagnostic approaches. In vivo studies have revealed that administration of the peptide improves glucose tolerance, providing a new therapeutic avenue for diabetes therapy and decreasing body weight, thus serving as a novel obesity therapy. The generation of synthetic analogs further enhances or abrogates activity relative to the natural peptide.

Career Highlights

Kelvin Yen is affiliated with the University of Southern California, where he continues to advance his research and innovations in the field of health sciences. His work has garnered attention for its potential impact on treating diabetes and obesity.

Collaborations

Kelvin collaborates with Pinchas Cohen, a fellow researcher, to further explore the implications of their findings in therapeutic applications.

Conclusion

Kelvin Yen's innovative work in developing MENTSH analogs represents a significant advancement in the fight against diabetes and obesity. His contributions are paving the way for new therapeutic strategies that could improve the lives of many individuals affected by these conditions.

Profile summary based on public USPTO records.